2-(4-Chloro-phenyl)-butane-1,4-diol | 91154-08-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-Chloro-phenyl)-butane-1,4-diol
• 英文别名: 2-(4-Chlorophenyl)butane-1,4-diol
• CAS: 91154-08-4
• 化学式: C₁₀H₁₃ClO₂
• 分子量: 200.665
• InChiKey: IFRCBYARRYNVPQ-UHFFFAOYSA-N

物化性质

• 沸点：
  341.6±27.0 °C(Predicted)
• 密度：
  1.231±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(4-Chloro-phenyl)-butane-1,4-diol 在 盐酸 、 4-二甲氨基吡啶 、 三乙胺 作用下， 以 丙酮 为溶剂， 反应 24.0h， 生成 4-[3-(4-Chlorophenyl)pyrrolidin-1-yl]-1-(4-fluorophenyl)butan-1-one
  参考文献：
  名称：

  Design, Synthesis, and Evaluation of Metabolism-Based Analogues of Haloperidol Incapable of Forming MPP+-like Species

  摘要：

  The long-term, irreversible, Parkinsonism-like side effects of haloperidol have been speculated to involve several mechanisms. More recently, it has been speculated that the metabolic transformation to MPP+-like species may contribute to the Parkinsonism-like side effects. Because BCPP+ and its reduced analogue have been shown to possess the potential to destroy dopamine receptors in the nigrostriatum, we have designed new analogues of haloperidol lacking the structural features necessary to form neurotoxic quaternary species but retaining their dopamine-binding capacity. The most potent agent at the D2 receptor, the homopiperidine analogue 11, was found to be equipotent to haloperidol. It was also of interest to identify analogues with DA binding profiles similar to that of clozapine at the dopamine receptor subtypes. Evaluation of the proposed agents shows that the ratio of D2 to D4 (2) binding of clozapine was mimicked by 7 [K-i(D2) = 33, K-i(D3) = 200, K-i(D4) = 11 nM; K-i(D2)/K-i(D4) = 3] and 9 [K-i(D2) = 44, K-i(D3) = 170, K-i(D4) = 24 nM; K-i(D2)/K-i(D4) = 2]. A preliminary in-vivo testing of compound 7 shows that its behavioral profile is similar to that of clozapine. This profile suggests that there is a need for further evaluation of these two synthetic agents and their enantiomers for efficacy and lack of catalepsy in animal models.

  DOI：

  10.1021/jm0301033
• 作为产物：
  描述：

  对氯苯乙腈 在 palladium on activated charcoal lithium aluminium tetrahydride 、 硫酸 、 氢气 、 potassium carbonate 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 为溶剂， 反应 90.0h， 生成 2-(4-Chloro-phenyl)-butane-1,4-diol
  参考文献：
  名称：

  Design, Synthesis, and Evaluation of Metabolism-Based Analogues of Haloperidol Incapable of Forming MPP+-like Species

  摘要：

  The long-term, irreversible, Parkinsonism-like side effects of haloperidol have been speculated to involve several mechanisms. More recently, it has been speculated that the metabolic transformation to MPP+-like species may contribute to the Parkinsonism-like side effects. Because BCPP+ and its reduced analogue have been shown to possess the potential to destroy dopamine receptors in the nigrostriatum, we have designed new analogues of haloperidol lacking the structural features necessary to form neurotoxic quaternary species but retaining their dopamine-binding capacity. The most potent agent at the D2 receptor, the homopiperidine analogue 11, was found to be equipotent to haloperidol. It was also of interest to identify analogues with DA binding profiles similar to that of clozapine at the dopamine receptor subtypes. Evaluation of the proposed agents shows that the ratio of D2 to D4 (2) binding of clozapine was mimicked by 7 [K-i(D2) = 33, K-i(D3) = 200, K-i(D4) = 11 nM; K-i(D2)/K-i(D4) = 3] and 9 [K-i(D2) = 44, K-i(D3) = 170, K-i(D4) = 24 nM; K-i(D2)/K-i(D4) = 2]. A preliminary in-vivo testing of compound 7 shows that its behavioral profile is similar to that of clozapine. This profile suggests that there is a need for further evaluation of these two synthetic agents and their enantiomers for efficacy and lack of catalepsy in animal models.

  DOI：

  10.1021/jm0301033

文献信息

• Iridium-Catalyzed Enantioselective Allyl–Allyl Cross-Coupling of Racemic Allylic Alcohols with Allylboronates
  作者：Yu Zheng、Bei-Bei Yue、Kun Wei、Yu-Rong Yang

  DOI：10.1021/acs.orglett.8b03627

  日期：2018.12.21

  catalytic system that allows asymmetric allyl–allylboronate cross-coupling with high enantioselectivity is reported. This transformation tolerates a large variety of racemic branched allylic alcohols and allylboronate substrates. The utility of the coupling is demonstrated in a concise catalytic asymmetric synthesis of (−)-preclamol.

  据报道，Carreira的铱-（P，烯烃）亚磷酰胺基催化体系可实现不对称的烯丙基-烯丙基硼酸酯不对称交联和高对映选择性。这种转化耐受各种各样的外消旋支链烯丙基醇和烯丙基硼酸酯底物。偶联的效用在简明的（-）-preclamol催化不对称合成中得到了证明。
• A NEW SYNTHESIS OF trans-2-SUBSTITUTED-2-BUTENE-1,4-DIOLS FROM 2-BUTYNE-1,4-DIOL VIA NUCLEOPHILIC ADDITION OF GRIGNARD REAGENTS
  作者：Yoshio Ishino、Kohji Wakamoto、Tsuneaki Hirashima

  DOI：10.1246/cl.1984.765

  日期：1984.5.5

  trans-2-Substituted-2-butene-1,4-diols were readily obtained by reactions of 2-butyne-1,4-diol with Grignard reagents in good yields.

  trans-2-Substituted-2-butene-1,4-diols 很容易通过 2-butyne-1,4-diol 与 Grignard 试剂以良好的产率反应获得。
• ISHINO, YOSHIO;WAKAMOTO, KOHJI;HIRASHIMA, TSUNEAKI, CHEM. LETT., 1984, N 5, 765-768
  作者：ISHINO, YOSHIO、WAKAMOTO, KOHJI、HIRASHIMA, TSUNEAKI

  DOI：——

  日期：——